Liposomal Amphotericin B: Therapeutic Use in the Management of Fungal Infections and Visceral Leishmaniasis

By Coukell A.J.   Brogden R.N.  

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 585-612

Adis International

Access to resources Recommend Favorite

New Formulations and Derivatives of Amphotericin B for Treatment of Leishmaniasis

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 153-162

Bentham Science Publishers

Access to resources Recommend Favorite

Liposomal Amphotericin B and HIV-Associated Visceral Leishmaniasis: Concerns about Nephrotoxicity and Administration Schedule

By Sergio Sabbatani   Roberto Manfredi   Ginevra Marinacci   Michele Pavoni   Michele Nafissi   Francesco Chiodo  

Clinical Drug Investigation, Vol. 25, Iss. 1, 2005-01 ,pp. : 85-87

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections

By Kuti J.L.  

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 301-310

Adis International

Access to resources Recommend Favorite

Amphotericin B liposomal: Pseudohyperphosphataemia: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite